Quest Diagnostics Issues $500M in 5.000% Senior Notes Due 2036, Finalizing Recent Offering

summarizeSummary

Quest Diagnostics has completed its previously announced debt offering, issuing $500 million in 5.000% senior notes due 2036 to bolster its capital structure.

check_boxKey Events

• Debt Offering Closed

  Quest Diagnostics issued $500 million aggregate principal amount of 5.000% senior notes due 2036 on May 6, 2026.

• Maturity and Interest

  The notes mature on June 30, 2036, with interest payable semi-annually starting December 30, 2026.

• Senior Unsecured Status

  The notes are senior unsecured obligations, ranking equally with the company's other existing and future senior unsecured debt.

• Change of Control Provision

  The indenture includes a provision requiring the company to offer to repurchase the notes at 101% of principal plus accrued interest upon a change of control triggering event.

auto_awesomeAnalysis

This 8-K confirms the actual issuance of $500 million in 5.000% senior notes due 2036, following the finalization of terms announced on April 27, 2026. While the market was aware of the offering, this filing signifies the successful closing of the transaction, providing Quest Diagnostics with substantial capital. The 5.000% interest rate and 2036 maturity are standard for a company of this credit profile. The proceeds will likely be used for general corporate purposes, potentially including funding the existing share repurchase program or other strategic investments.